tiprankstipranks
Trending News
More News >
Medifast Inc (MED)
NYSE:MED
Advertisement

Medifast (MED) Price & Analysis

Compare
1,237 Followers

MED Stock Chart & Stats


Medifast News

MED FAQ

What was Medifast Inc’s price range in the past 12 months?
Medifast Inc lowest stock price was $11.57 and its highest was $21.98 in the past 12 months.
    What is Medifast Inc’s market cap?
    Medifast Inc’s market cap is $154.20M.
      When is Medifast Inc’s upcoming earnings report date?
      Medifast Inc’s upcoming earnings report date is Feb 24, 2026 which is in 176 days.
        How were Medifast Inc’s earnings last quarter?
        Medifast Inc released its earnings results on Aug 04, 2025. The company reported $0.401 earnings per share for the quarter, beating the consensus estimate of -$0.19 by $0.591.
          Is Medifast Inc overvalued?
          According to Wall Street analysts Medifast Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medifast Inc pay dividends?
            Medifast Inc pays a Quarterly dividend of $1.65 which represents an annual dividend yield of N/A. See more information on Medifast Inc dividends here
              What is Medifast Inc’s EPS estimate?
              Medifast Inc’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Medifast Inc have?
              Medifast Inc has 10,991,064 shares outstanding.
                What happened to Medifast Inc’s price movement after its last earnings report?
                Medifast Inc reported an EPS of $0.401 in its last earnings report, beating expectations of -$0.19. Following the earnings report the stock price went down -3.257%.
                  Which hedge fund is a major shareholder of Medifast Inc?
                  Currently, no hedge funds are holding shares in MED

                  Company Description

                  Medifast Inc

                  Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

                  Medifast (MED) Earnings & Revenues

                  MED Company Deck

                  MED Earnings Call

                  Q2 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Negative
                  The earnings call presented a mixed picture: while Medifast reported some positive developments such as exceeding guidance, improving coach productivity, and a strong financial position, these were overshadowed by significant declines in revenue and active coaches, as well as challenges in new coach acquisition. The company's cautious third quarter guidance further indicates ongoing struggles.View all MED earnings summaries
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  MEDIROM Healthcare Technologies

                  Ownership Overview

                  4.71%14.65%8.82%53.28%
                  8.82% Other Institutional Investors
                  53.28% Public Companies and
                  Individual Investors
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis